{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T16:23:05Z","timestamp":1779380585530,"version":"3.53.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.drugalcdep.2010.03.006","type":"journal-article","created":{"date-parts":[[2010,4,29]],"date-time":"2010-04-29T08:37:31Z","timestamp":1272530251000},"page":"228-233","source":"Crossref","is-referenced-by-count":38,"title":["Optimal targeting of Hepatitis C virus treatment among injecting drug users to those not enrolled in methadone maintenance programs"],"prefix":"10.1016","volume":"110","author":[{"given":"Irmgard","family":"Zeiler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Langlands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2010.03.006_bib1","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1002\/hep.22534","article-title":"High incidence of hepatitis C virus reinfection in a cohort of injecting drug users","volume":"48","author":"Aitken","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.drugalcdep.2010.03.006_bib2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jcv.2007.12.007","article-title":"Consecutive infections and clearances of different hepatitis C virus genotypes in an injecting drug user","volume":"41","author":"Aitken","year":"2008","journal-title":"Journal of Clinical Virology"},{"key":"10.1016\/j.drugalcdep.2010.03.006_bib3","series-title":"Alcohol and Other Drug Treatment Services in Australia: Report on the National Minimum Data Sets 2006\u20132007","author":"Australian Institute of Health and Welfare (AIHW)","year":"2007"},{"key":"10.1016\/j.drugalcdep.2010.03.006_bib4","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1086\/425361","article-title":"Infrequent reinfection after successful treatment for hepatitis C virus infection in injection drug users","volume":"39","author":"Backmund","year":"2004","journal-title":"Clinical Infectious Diseases"},{"issue":"Suppl. 5","key":"10.1016\/j.drugalcdep.2010.03.006_bib5","doi-asserted-by":"crossref","first-page":"S330","DOI":"10.1086\/427475","article-title":"Hepatitis C virus infection and injection drug users: prevention, risk factors, and treatment","volume":"40","author":"Backmund","year":"2005","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.drugalcdep.2010.03.006_bib6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/09595230500537647","article-title":"Retention and attendance with supervised buprenorphine treatment: a case-note review","volume":"25","author":"Bell","year":"2006","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.drugalcdep.2010.03.006_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.drugalcdep.2005.05.010","article-title":"Cycling in and out of treatment; participation in methadone treatment in NSW, 1990\u20132002","volume":"81","author":"Bell","year":"2006","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugalcdep.2010.03.006_bib8","unstructured":"Centers for Disease Control and Prevention, 2009. Surveillance for Acute Viral Hepatitis \u2013 United States, 2007. Surveillance Summaries, MMWR 58 (No. SS-3)."},{"key":"10.1016\/j.drugalcdep.2010.03.006_bib9","series-title":"Modelling pharmacotherapy maintenance in Australia: exploring affordability, availability, accessibility and quality using system dynamics. ANCD Research Paper 19","author":"Chalmers","year":"2009"},{"key":"10.1016\/j.drugalcdep.2010.03.006_bib10","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1369-1600.2009.00148.x","article-title":"Retention rate and side effects in a prospective trial on hepatitis C treatment with pegylated interferon alpha-2a and ribavirin in opioid-dependent patients","volume":"14","author":"Ebner","year":"2009","journal-title":"Addiction Biology"},{"key":"10.1016\/j.drugalcdep.2010.03.006_bib11","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJM200107193450311","article-title":"Is it justifiable to withhold treatment for Hepatitis C from illicit drug users?","volume":"345","author":"Edlin","year":"2001","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.drugalcdep.2010.03.006_bib12","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/hep.21376","article-title":"Hepatitis C virus reinfection in injection drug users","volume":"44","author":"Grebely","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.drugalcdep.2010.03.006_bib13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev.pathol.1.110304.100230","article-title":"Immunobiology and pathogenesis of viral hepatitis","volume":"1","author":"Guidotti","year":"2006","journal-title":"Annual Reviews in Pathology"},{"key":"10.1016\/j.drugalcdep.2010.03.006_bib14","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1128\/JVI.79.7.4340-4346.2005","article-title":"Wide range of quasispecies diversity during primary hepatitis C virus infection","volume":"79","author":"Herring","year":"2005","journal-title":"Journal of Virology"},{"key":"10.1016\/j.drugalcdep.2010.03.006_bib15","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.drugpo.2006.12.018","article-title":"The drugs that dare not speak their name: injecting and other illicit drug use during treatment for hepatitis C infection","volume":"18","author":"Hopwood","year":"2007","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.drugalcdep.2010.03.006_bib16","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.socscimed.2008.10.011","article-title":"A meta-analysis of the hepatitis C virus distribution in diverse racial\/ethnic drug injector groups","volume":"68","author":"Lelutiu-Weinberger","year":"2009","journal-title":"Social Science & Medicine"},{"key":"10.1016\/j.drugalcdep.2010.03.006_bib17","doi-asserted-by":"crossref","first-page":"S325","DOI":"10.1086\/427448","article-title":"Treatment for hepatitis C virus infection among current injection drug users in Australia","volume":"40","author":"Matthews","year":"2005","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.drugalcdep.2010.03.006_bib18","series-title":"National Evaluation of Pharmacotherapies for opioid Dependence (NEPOD): Report of Results and Recommendations. National Drug Strategy Monograph Series","author":"Mattick","year":"2001"},{"key":"10.1016\/j.drugalcdep.2010.03.006_bib19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2893.2005.00651.x","article-title":"Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies","volume":"13","author":"Micallef","year":"2006","journal-title":"Journal of Viral Hepatitis"},{"key":"10.1016\/j.drugalcdep.2010.03.006_bib20","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/09595230701373883","article-title":"The costs and consequences of three policy options for reducing heroin dependency","volume":"26","author":"Moore","year":"2007","journal-title":"Drug Alcohol Review"},{"key":"10.1016\/j.drugalcdep.2010.03.006_bib21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0025-5564(98)10046-9","article-title":"A model of primary HIV-1 infection","volume":"154","author":"Murray","year":"1998","journal-title":"Mathematical Biosciences"},{"key":"10.1016\/j.drugalcdep.2010.03.006_bib22","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/ije\/dyg102","article-title":"The impact of behavioural changes on the prevalence of human immunodeficiency virus and hepatitis C among injecting drug users","volume":"32","author":"Murray","year":"2003","journal-title":"International Journal of Epidemiology"},{"key":"10.1016\/j.drugalcdep.2010.03.006_bib23","series-title":"HIV\/AIDS, Viral Hepatitis and Sexually Transmissible Infections In Australia Annual Surveillance Report 2003","author":"National Centre in HIV Epidemiology and Clinical Research","year":"2003"},{"key":"10.1016\/j.drugalcdep.2010.03.006_bib24","series-title":"HIV\/AIDS, Viral Hepatitis and Sexually Transmissible Infections In Australia Annual Surveillance Report 2007","author":"National Centre in HIV Epidemiology and Clinical Research","year":"2003"},{"key":"10.1016\/j.drugalcdep.2010.03.006_bib25","series-title":"HIV\/AIDS, Viral Hepatitis and Sexually Transmissible Infections In Australia Annual Surveillance Report 2008","author":"National Centre in HIV Epidemiology and Clinical Research","year":"2003"},{"key":"10.1016\/j.drugalcdep.2010.03.006_bib26","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1360-0443.2008.02188.x","article-title":"Critical issues in the treatment of hepatitis C virus infection in methadone maintenance patients","volume":"103","author":"Novick","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2010.03.006_bib27","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1445-5994.1999.tb00779.x","article-title":"Severity of liver disease in hepatitis c infection contracted through injecting drug use","volume":"29","author":"Ostapowicz","year":"1999","journal-title":"Australian and New Zealand Journal of Medicine"},{"key":"10.1016\/j.drugalcdep.2010.03.006_bib28","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.drugalcdep.2007.05.026","article-title":"Modelling the hepatitis C virus epidemic in Australia","volume":"91","author":"Razali","year":"2007","journal-title":"Drug Alcohol Dependence"},{"key":"10.1016\/j.drugalcdep.2010.03.006_bib29","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jhep.2008.07.005","article-title":"Acute hepatitis C: current status and remaining challenges","volume":"49","author":"Santantonio","year":"2008","journal-title":"Journal of Hepatology"},{"issue":"Suppl. 5","key":"10.1016\/j.drugalcdep.2010.03.006_bib30","doi-asserted-by":"crossref","first-page":"S321","DOI":"10.1086\/427447","article-title":"Treating hepatitis C virus infection in active substance users","volume":"40","author":"Sylvestre","year":"2005","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.drugalcdep.2010.03.006_bib31","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.drugalcdep.2005.11.009","article-title":"One year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS)","volume":"83","author":"Teesson","year":"2006","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugalcdep.2010.03.006_bib32","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1084\/jem.194.10.1395","article-title":"Determinants of viral clearance and persistence during acute Hepatitis C virus infection","volume":"194","author":"Thimme","year":"2001","journal-title":"Journal of Experimantal Medicine"},{"key":"10.1016\/j.drugalcdep.2010.03.006_bib33","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1465-3362.2009.00031.x","article-title":"Hepatitis C treatment in pharmacotherapy services: increasing treatment uptake needs a critical view","volume":"28","author":"Treloar","year":"2009","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.drugalcdep.2010.03.006_bib34","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1097\/00002030-200111230-00010","article-title":"Acute HIV infection: impact on the spread of HIV and transmission of drug resistance","volume":"15","author":"Yerly","year":"2001","journal-title":"Aids"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871610001067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871610001067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T13:27:55Z","timestamp":1544534875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871610001067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0376871610001067"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2010.03.006","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}